Glaucoma pathophysiology and treatment

Glaucoma remains a significant global cause of irreversible blindness, posing a formidable challenge to ophthalmologists and researchers worldwide. This specialized conference track aims to convene ophthalmologists, researchers, clinicians, and industry experts to explore the latest advancements, challenges, and innovations in the field of glaucoma pathophysiology and treatment.

Key Themes and Topics:

1. Pathophysiology of Glaucoma: Explore the complex pathophysiological mechanisms underlying glaucoma, including intraocular pressure (IOP) regulation, optic nerve head damage, retinal ganglion cell apoptosis, neuroinflammation, and vascular dysregulation.
2. Diagnostic Modalities: Discuss the latest advancements in glaucoma diagnostic techniques, including optical coherence tomography (OCT), visual field testing, optic nerve imaging, and intraocular pressure monitoring, for early detection and monitoring of glaucomatous damage.
3. Primary Open-Angle Glaucoma (POAG): Review the epidemiology, risk factors, and genetic predisposition associated with POAG, the most common form of glaucoma worldwide. Explore current treatment modalities, including topical medications, laser therapy, and surgical interventions, for IOP control and disease management.
4. Angle-Closure Glaucoma: Discuss the clinical features, pathophysiology, and management of angle-closure glaucoma, including acute angle-closure crisis and chronic angle-closure glaucoma. Evaluate treatment options, such as peripheral iridotomy, trabeculectomy, and cataract extraction, to alleviate angle closure and prevent optic nerve damage.
5. Normal-Tension Glaucoma (NTG): Examine the diagnostic challenges and treatment strategies for normal-tension glaucoma, characterized by optic nerve damage and visual field loss in the absence of elevated IOP. Explore neuroprotective agents, ocular perfusion enhancers, and surgical interventions for IOP-independent mechanisms of optic nerve damage.